Lesopitron
Lesopitron is a selective serotonin receptor antagonist developed by Esteve. It is an anxiolytic drug of the azapirone class, similar to other azapirones like buspirone and ipsapirone.
Pharmacology[edit | edit source]
Lesopitron acts as a 5-HT1A receptor antagonist. The 5-HT1A receptor is a subtype of the 5-HT receptor that binds the neurotransmitter serotonin, and is prevalent in the cerebral cortex, hippocampus, septum, amygdala, and raphe nucleus, all of which are areas associated with anxiety and depression.
Clinical Use[edit | edit source]
Lesopitron is primarily used in the treatment of generalized anxiety disorder (GAD). It has been shown to have similar efficacy to benzodiazepines in treating GAD, but with fewer side effects such as sedation and dependency.
Side Effects[edit | edit source]
Common side effects of Lesopitron include dizziness, nausea, and headache. Less common side effects can include dry mouth, constipation, and changes in weight. As with all medications, it is important to monitor for any unusual or severe side effects and report them to a healthcare provider.
See Also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Template:Serotonin receptor antagonists
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD
